BBA
INSM icon

Baader Bank Aktiengesellschaft’s Insmed INSM Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,032
Closed -$712K – 528
2025
Q3 		$712K Buy
+5,032
New +$616K 0.05% 223

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Baader Bank Aktiengesellschaft's INSM Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of Insmed (INSM) in Q4 2025, closing a stake of 5,032 shares — an estimated $712K sold.

Baader Bank Aktiengesellschaft first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $712K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Baader Bank Aktiengesellschaft reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 5,032 Insmed shares in Q4 2025, an estimated $712K.
  • Baader Bank Aktiengesellschaft first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Insmed position peaked at $712K in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.